Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Remigio M Olveda
Efficacy and Safety of Praziquantel for the Treatment of Human Schistosomiasis During Pregnancy: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet Infectious Diseases
Infectious Diseases
Health Education and the Control of Intestinal Worm Infections in China: A New Vision
Parasites and Vectors
Parasitology
Infectious Diseases
Related publications
Efficacy and Safety of Analgesic Treatment for Depression in People With Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
Drugs and Aging
Gerontology
Geriatrics
Pharmacology
Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
Alcoholism: Clinical and Experimental Research
Medicine
Psychiatry
Mental Health
Toxicology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
Randomised, Double Blind, Placebo Controlled Clinical Trial of Efficacy of Vitamin a Treatment in Non-Measles Childhood Pneumonia
BMJ
Safety and Efficacy of Opicinumab in Acute Optic Neuritis (RENEW): A Randomised, Placebo-Controlled, Phase 2 Trial
The Lancet Neurology
Neurology
Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial
Pediatrics
Child Health
Pediatrics
Perinatology
Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
The Lancet
Medicine
Limited Effect of Sulphasalazine Treatment in Reactive Arthritis. A Randomised Double Blind Placebo Controlled Trial
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Efficacy and Safety of Once-Weekly Semaglutide Monotherapy Versus Placebo in Patients With Type 2 Diabetes (SUSTAIN 1): A Double-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multinational, Multicentre Phase 3a Trial
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
